ResMed (RMD) Said Mick FarrelL to Suceed Peter Farrell as CEO
Tweet Send to a Friend
ResMed, Inc. (NYSE: RMD) announced today that effective March 1, 2013, Michael ("Mick") Farrell will succeed Dr. Peter C. Farrell ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
